Richard Dennett

Tim Adetona, M.Sc., D.PH

Tim has a broad regulatory expertise of close to 20 years’ experience (5 as Consultant) in addressing and obtaining regulatory authorization for various life-science products including drugs, biologics and innovative nutritional products in Europe, as well as statutory regulatory requirements in global markets including the USA and emerging markets.

Tim has acquired significant knowledge of Swiss regulations and Swissmedic procedures and has successfully managed a number of MAA submissions for drugs and biologics. Tim has substantial experience in all steps of product development from preclinical to life-cycle management, including those involving specialized conditions as orphan drug designations, accelerated or fast-track assessment procedures and compassionate use programs.

Tim also has responsibility for the management of projects involving the design and implementation of global regulatory strategies for the development, evaluation and marketing of nutritional and innovative food-drug borderline products. Tim is equally well versed in regulatory engagements involved with the development of Personal, Health and Beauty Care products (cosmetics, deodorants and antiperspirants), as well as Medical Devices and OTC medicines.

Prior to joining VCLS, Tim was Regulatory Affairs Director, Consumer Health Care International (CHCI) for Vifor Pharma, where he provided directional leadership for the implementation of all aspects of Regulatory Affairs related to Consumer Health Care products in global markets and successfully expanded the experience he had gained as Senior Regulatory Affairs Manager for Procter & Gamble.

Kim Nguyen, PhD

Kim is a part of the Cell Therapy team at Precision Biosciences focused on the process development, analytics, and manufacturing of allogeneic CAR-T cell products. Before joining Precision Biosciences, she served as Principal Scientist and Senior Manager for Strategic Initiatives at Terumo BCT. Kim received her AB from Princeton University and her Ph.D. from Columbia University, both in Chemistry. She enjoys cooking Vietnamese food, reading, and adventures with her adorable Jack Russell terrier, Grover, aka Mr. Shambles.

Dr Zoltan Ivics

Ryan Aresnault

Dr. Ryan Arsenault is currently an Assistant Professor in the Department of Animal and Food Sciences at the University of Delaware. Dr. Arsenault’s research at UD centers on kinomics and gut health across food-animal species, and includes the topics of immunometabolism, host-pathogen interactions, feed additives and antibiotic alternatives. Dr. Arsenault was previously a post-doctoral research scientist with the United States Department of Agriculture’s Agricultural Research Service (USDA-ARS) where he conducted research on gut health and immunomodulation in chicken and cattle, with the goal of limiting the carry and spread of pathogens important to food safety. Dr. Arsenault received his B.Sc. (2006) and Ph.D. (2012) from the University of Saskatchewan, Canada, in biochemistry and conducted his research at the Vaccine and Infectious Disease Organization - International Vaccine Centre (VIDO-InterVac). 

Julie Veryser

Jan Suchodolski

Jan S. Suchodolski graduated with a veterinary degree from the University of Veterinary Medicine in Vienna, Austria in 1997. In 2005 Dr. Suchodolski received his PhD in Veterinary Microbiology from Texas A&M University for his work on molecular markers for the assessment of the intestinal microbiota. He is board certified in immunology by the American College of Veterinary Microbiologists (ACVM). He currently serves as Associate Professor and Associate Director of the GI Lab, a leading research and service laboratory for diagnosis of gastrointestinal disease in companion animals. Over the last 10 years, the GI Laboratory has developed and validated several novel biomarkers for diagnosing and assessing severity of disease in gastrointestinal inflammation and microbiota dysbiosis. His research interest focusses on characterization of intestinal microbiota and metabolome in animal models with spontaneously occurring inflammatory bowel diseases and how the perturbations are modulated by various treatments.  

Brandon Reinbold

Dr. Yeoman

Dr. Yeoman’s research seeks to uncovering the various forces shaping the structure and function of host-associated microbial communities and understanding their impact on host nutrition, health and development. His work to date has focussed on the microbial communities associated with humans, wild and captive primates, and various agriculturally-important livestock species, including cattle and sheep and transcends gastrointestinal and reproductive tract niches. Dr Yeoman’s research employees multiple molecular methods and often involves longitudinal and biospatial analyses which he believes are critical to understanding the true impact of the microbiota.

Dr. Bryan White

Dr. Bryan White is a Professor Emeritus of Animal Sciences in the Carl R. Woese Institute for Genomic Biology, and the Director of the Mayo Clinic and University of Illinois Alliance for Technology-Based Healthcare.  Dr. White is has published over 145 peer review manuscripts and received over $13M in competitive grants from the USDA, DOE, NSF and NIH.   White’s major research interests are in using microbial physiology, genomics and metagenomics, and ecology to understand host-microbe interactions in vertebrates.  His laboratory has used animal models that address fiber utilization in domestic animal species for understanding nutrition and food safety.  His work with human and non-human primate gastrointestinal and reproductive tracts address the role of the microbiome in women’s reproductive health, the development of autoimmune diseases, cancer etiology and prevention, and evolution of the host.  In 2015 he was elected as a Fellow in the American Academy of Microbiology.